Vivo Bio Tech Limited has submitted a regulatory disclosure to BSE Limited regarding the expiry of certain convertible equity warrants.
The disclosure, made under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, informs that 483 (Four Hundred and Eighty Three) Convertible Equity Warrants have expired. These warrants were part of a larger preferential allotment of 26,00,000 (Twenty Six Lakhs) Convertible Equity Warrants issued to Antique Infotech Private Limited.
Key Details of the Original Allotment:
- Allotment Date: February 20, 2025
- Issue Price: ₹45 per warrant (comprising a Face Value of ₹10 and a Premium of ₹35)
- Allotment Type: Preferential basis
Reason for Expiry:
The warrants expired due to non-exercise by the holder before the completion of their tenure. The tenure for these instruments was eighteen months from the date of allotment, as stipulated under Regulation 162 of the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018.
Effective Date of Expiry:
The expiry became effective on August 20, 2026, which marks eighteen months from the original allotment date of February 20, 2025.
The company has submitted this information for the exchange's records and compliance purposes. The letter was signed by Bhavish Vijayvargiya (Company Secretary, Membership No. A77631) on behalf of Vivo Bio Tech Limited.